Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Amocobal
- Development stage
- Unknown
- Lead developer
- Ergos Life Sciences
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
**Amocobal** is an oral nutraceutical fixed-dose combination developed by A S Pharmaceutical containing methylcobalamin, folic acid, vitamin B1, vitamin B6, and alpha lipoic acid. It is intended to replenish B-vitamin and folate deficiencies while providing alpha lipoic acid antioxidant support; these components support neuronal metabolic function and are used for nutritional deficiency and neuropathy-related supportive care.
- Brand names
- Amocobal
- Other names
- Alpha lipoic acid + folic acid + methylcobalamin + pyridoxine + thiamineMethylcobalamin + folic acid + vitamin B1 + vitamin B6 + alpha lipoic acid capsules
Beyond the preview
Go deeper on Amocobal.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Amocobal.